...
首页> 外文期刊>Journal of Thoracic Disease >Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease
【24h】

Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease

机译:患有N2病的非小细胞肺癌手术患者的五年生存分析和预后因素

获取原文

摘要

Background: The aim of the study is to analyse 5-year survival and prognostic factors in patients operated due to lung cancer with postoperatively confirmed metastases to N2 group nodes. Methods: In the years 2007–2015, 1,148 patients with lung cancer were treated surgically. A postoperative histopathological study confirmed N2 feature in 150 patients. One hundred and ten patients, in whom a 5-year survival analysis was possible to perform, were included in such analysis. The patients underwent the following procedures: pneumonectomy, 31 patients; lobectomy, 61; bilobectomy, 10; and wedge resection, 8. All patients were subjected to supplementary treatment after the surgery. Results: Five-year survival was achieved in 23 patients (21%). The patients’ survival did not depend on the type of surgery, type of tumour, its location or presence of metastases in N1 nodes (P=0.82, P=0.51, P=0.36 and P=0.23, respectively). A statistically significant correlation was observed (P=0.01) between the 5-year survival of a patient and the occurrence of metastases only in one group of lymph nodes of the N2 feature (22 patients, 20%). Involvement of three or more mediastinal nodal groups resulted in survival shorter than 5-year. Conclusions: (I) In patients with the N2 feature, the type of performed surgery, type of tumour and the occurrence of metastases in the lymph nodes of the lung hilum do not affect 5-year survival; (II) involvement of only one nodal group allows to achieve 5-year survival in 20% of patients; (III) involvement of three and more nodal groups with the N2 feature results in decreased 5-year survival.
机译:背景:本研究的目的是分析因肺癌手术后被确诊为N2组淋巴结转移的患者的5年生存率和预后因素。方法:在2007–2015年间,对1,148例肺癌患者进行了手术治疗。一项术后组织病理学研究证实了150例患者的N2特征。此类分析包括110名可能进行5年生存期分析的患者。患者接受以下手术:肺切除术31例;肺叶切除术; 61;双叶切除术,10;楔形切除术。8.术后所有患者均接受了补充治疗。结果:23名患者(21%)实现了五年生存。患者的存活率不取决于手术类型,肿瘤类型,其在N1个淋巴结中的位置或转移的存在(分别为P = 0.82,P = 0.51,P = 0.36和P = 0.23)。观察到患者的5年生存率和仅在一组N2特征淋巴结中发生转移(22例患者,20%)之间存在统计学上的显着相关性(P = 0.01)。涉及三个或更多纵隔淋巴结组导致生存期短于5年。结论:(I)具有N2特征的患者,手术类型,肿瘤类型以及肺门淋巴结转移的发生均不影响5年生存率; (II)仅一个淋巴结受累组可在20%的患者中实现5年生存; (III)具有N2特征的三个或更多节点组的参与导致5年生存期缩短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号